Optimal Treatment for Recurrent Clostridium Difficile

Clinical trial NCT02667418 · TERMINATED

Trial details

NCT number: NCT02667418
Sponsor: VA Office of Research and Development
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Clostridium Difficile Fidaxomicin Vancomycin

Start date: 2016-02-19
Primary completion: 2024-08-07
Enrollment: 308

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.